Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#81 / 175 Total
FHTX - Foghorn Therapeutics Inc - Stock Price Chart
TickerFHTX [NASD, RUT]
CompanyFoghorn Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap267.00MEPS (ttm)-1.40
P/E-EPS this Y20.09%
Forward P/E-EPS next Y7.33%
PEG-EPS past 5Y-2.59%
P/S11.36EPS next 5Y6.99%
P/B-EPS Q/Q49.17%
Dividend-Sales Q/Q17.86%
Insider Own49.95%Inst Own41.82%
Insider Trans0.00%Inst Trans0.63%
Short Float3.94%EarningsMay 14/b
Analyst Recom1.25Target Price10.57
Avg Volume125.02K52W Range2.94 - 10.25
Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology. Through its scalable Gene Traffic Control product platform, the firm is systematically interrogating and drugging the chromatin regulatory system. The company was founded by Cigall Kadoch, Gerald W. Crabtree and Douglas G. Cole in October 2015 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Costa CarlosChief People OfficerSep 20 '24Option Exercise3.7235,756133,01235,756Sep 24 04:01 PM
Costa CarlosChief People OfficerSep 23 '24Option Exercise3.728573,188857Sep 24 04:01 PM
Costa CarlosChief People OfficerSep 20 '24Sale10.0435,756358,9900Sep 24 04:01 PM
Costa CarlosChief People OfficerSep 23 '24Sale10.178578,7160Sep 24 04:01 PM
Costa CarlosChief People OfficerSep 18 '24Option Exercise3.7211,57443,05511,574Sep 20 04:00 PM
THAR - Tharimmune Inc - Stock Price Chart
TickerTHAR [NASD]
CompanyTharimmune Inc
CountryUSA
IndustryBiotechnology
Market Cap3.83MEPS (ttm)-7.79
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y29.89%
P/S-EPS next 5Y-
P/B-EPS Q/Q65.67%
Dividend-Sales Q/Q-
Insider Own1.66%Inst Own2.56%
Insider Trans13.85%Inst Trans-54.00%
Short Float1.70%EarningsFeb 26
Analyst Recom1.00Target Price5.00
Avg Volume126.36K52W Range0.95 - 6.39
Jun-17-25 08:01AM Tharimmune Announces Key Leadership Appointments Including James Gordon Liddy Joining Board of Directors (ACCESSWIRE) +9.09%
May-19-25 08:01AM Tharimmune Appoints Renowned Counter-Terrorism and Critical Infrastructure Expert James Gordon Liddy (CDR US Navy SEAL (Ret)) as Key Strategic Advisor Against Weaponized Fentanyl and Other High-Potency Opioids Following Positive FDA Feedback (ACCESSWIRE) +7.79%
May-06-25 08:01AM Tharimmune Presents Positive Clinical Data Highlighting TH104 Metabolic Profile and Advances Program for Prophylaxis Against Ultrapotent Opioid Exposure Following FDA Feedback (ACCESSWIRE) +5.77%
May-01-25 08:01AM Tharimmune Abstracts Accepted for Presentation at Upcoming DDW and EASL Conferences (ACCESSWIRE) -10.40%
Apr-30-25 08:01AM Tharimmune Appoints Clay Kahler and Gary Stetz to its Board of Directors (ACCESSWIRE) +16.89%
Apr-28-25 08:01AM Tharimmune Advances TH104 for Prophylaxis Against Weaponized Fentanyl and Other High-Potency Opioids Following Positive FDA Feedback (ACCESSWIRE) +13.34%
Apr-15-25 09:00AM Tharimmune Strengthens Strategic Leadership with the Appointment of Vincent LoPriore to its Board of Directors (ACCESSWIRE)
Apr-07-25 08:00AM Tharimmune Announces Positive Data with Novel Biparatopic PD-1/VEGF and Multispecific HER2/HER3 Biologics Leveraging Proprietary EpiClick(TM) Technology (ACCESSWIRE)
Mar-31-25 08:00AM Tharimmune Announces Positive FDA Feedback on NDA Path for TH104 for Prophylaxis of Respiratory and/or CNS Depression for Ultrapotent Opioid Exposure (ACCESSWIRE)
Mar-04-25 07:00AM Tharimmune Announces Positive Target Engagement with Novel Biparatopic PD-1/VEGF and Multispecific HER2/HER3 Biologics Leveraging Proprietary EpiClick Technology (ACCESSWIRE)
Tharimmune, Inc. is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology. It also develops TH104, which is known to suppress chronic, debilitating pruritus or uncontrollable itching in PBC, a rare and orphan liver disease with no known cure. The company was founded on March 28, 2017 and is headquartered in Bridgewater, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Parikh SanamDirectorMay 15 '25Buy1.307701,001770May 16 04:15 PM
MILBY RANDYCEODec 19 '24Buy2.124,6009,75217,534Dec 20 08:00 PM
Appajosyula SireeshChief Operating OfficerNov 13 '24Buy2.025,00010,09610,758Nov 13 05:06 PM
MILBY RANDYCEOOct 08 '24Buy2.092,5005,22112,934Oct 10 04:15 PM
Appajosyula SireeshChief Operating OfficerOct 08 '24Buy1.935,0009,65016,364Oct 08 04:10 PM
CRK - Comstock Resources, Inc - Stock Price Chart
TickerCRK [NYSE, RUT]
CompanyComstock Resources, Inc
CountryUSA
IndustryOil & Gas E&P
Market Cap8.45BEPS (ttm)-1.12
P/E-EPS this Y426.05%
Forward P/E19.81EPS next Y86.16%
PEG-EPS past 5Y-
P/S6.11EPS next 5Y-
P/B3.98EPS Q/Q-611.75%
Dividend-Sales Q/Q52.74%
Insider Own73.32%Inst Own30.07%
Insider Trans-0.02%Inst Trans-2.80%
Short Float26.07%EarningsApr 30/a
Analyst Recom3.11Target Price21.19
Avg Volume2.20M52W Range7.74 - 26.50
Jun-17-25Upgrade Wolfe Research Peer Perform → Outperform $34
Comstock Resources, Inc. engages in the acquisition, development, and exploration of oil and natural gas. The firm operations concentrated in the Haynesville shale, a premier natural gas basin located in East Texas. The company was founded in 1919 and is headquartered in Frisco, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sanders LaRae LynnVice President of LandJun 14 '25Option Exercise0.0014,8830249,881Jun 17 04:27 PM
PRESLEY DANIEL KVP of AccountingJun 14 '25Option Exercise0.0015,8110264,024Jun 17 04:27 PM
Newell Clifford Doyle IIIChief Commercial OfficerJun 14 '25Option Exercise0.0019,4480108,904Jun 17 04:27 PM
Mills Ronald EugeneVP of Finance. and IRJun 14 '25Option Exercise0.0013,0450139,124Jun 17 04:27 PM
McGough PatrickVice President of OperationsJun 14 '25Option Exercise0.0015,8720231,865Jun 17 04:26 PM
COCP - Cocrystal Pharma Inc - Stock Price Chart
TickerCOCP [NASD]
CompanyCocrystal Pharma Inc
CountryUSA
IndustryBiotechnology
Market Cap16.18MEPS (ttm)-1.56
P/E-EPS this Y27.33%
Forward P/E-EPS next Y-13.60%
PEG-EPS past 5Y-2.62%
P/S-EPS next 5Y11.31%
P/B2.21EPS Q/Q41.82%
Dividend-Sales Q/Q-
Insider Own31.67%Inst Own7.36%
Insider Trans0.00%Inst Trans5.19%
Short Float0.20%EarningsMay 15/b
Analyst Recom1.00Target Price9.00
Avg Volume19.90K52W Range1.12 - 3.26
Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded in 2008 and is headquartered in Bothell, WA.
CREX - Creative Realities Inc - Stock Price Chart
TickerCREX [NASD]
CompanyCreative Realities Inc
CountryUSA
IndustrySoftware - Application
Market Cap38.60MEPS (ttm)-0.00
P/E-EPS this Y213.97%
Forward P/E12.77EPS next Y-25.81%
PEG-EPS past 5Y-
P/S0.80EPS next 5Y-
P/B1.28EPS Q/Q3170.48%
Dividend-Sales Q/Q-20.77%
Insider Own28.28%Inst Own19.56%
Insider Trans0.54%Inst Trans-9.44%
Short Float1.00%EarningsMay 14/b
Analyst Recom1.00Target Price6.62
Avg Volume105.10K52W Range1.28 - 5.20
Creative Realities, Inc. engages in the provision of digital marketing technology and solutions to retail companies, individual retail brands, enterprises, and other organizations. Its technology and solutions include digital merchandising systems, omni-channel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and interactive marketing technologies such as, point-of-sale transactions, beaconing and web-based media. The company was founded on March 23rd, 2000 and is headquartered in Louisville, KY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MILLS RICHARD CChief Executive OfficerJun 02 '25Buy3.2616,00052,182302,601Jun 04 09:21 PM
JBL - Jabil Inc - Stock Price Chart
TickerJBL [NYSE, S&P 500]
CompanyJabil Inc
CountryUSA
IndustryElectronic Components
Market Cap21.14BEPS (ttm)5.14
P/E38.28EPS this Y8.33%
Forward P/E18.67EPS next Y14.69%
PEG2.85EPS past 5Y43.90%
P/S0.74EPS next 5Y13.44%
P/B15.88EPS Q/Q91.51%
Dividend0.16%Sales Q/Q15.71%
Insider Own2.96%Inst Own97.75%
Insider Trans-4.15%Inst Trans-0.01%
Short Float3.71%EarningsJun 17/b
Analyst Recom1.73Target Price208.43
Avg Volume1.44M52W Range95.85 - 182.13
TodayUpgrade Argus Hold → Buy
Jabil, Inc. engages in the provision of manufacturing services and solutions. It operates through the Electronics Manufacturing Services (EMS) and Diversified Manufacturing Services (DMS) segments. The EMS segment focuses on leveraging information technology, supply chain design and engineering, technologies largely centered on core electronics, utilizing a large-scale manufacturing infrastructure, and the ability to serve a broad range of end markets. The DMS segment offers engineering solutions with an emphasis on material sciences, machining, tooling, and molding of engineered plastic and metal parts. The company was founded by William E. Morean and James Golden in 1966 and is headquartered in St. Petersburg, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MONDELLO MARK TOfficerJun 17 '25Proposed Sale193.33150,00029,000,000Jun 17 04:12 PM
Dastoor MichaelOfficerJun 17 '25Proposed Sale191.6618,2343,494,742Jun 17 04:07 PM
MONDELLO MARK TExecutive ChairmanJun 02 '25Sale166.7520,0003,335,0671,710,192Jun 04 04:48 PM
MONDELLO MARK TOfficerJun 02 '25Proposed Sale167.3020,0003,346,000Jun 02 04:09 PM
Dastoor MichaelCEOMay 14 '25Sale169.9010,0001,699,000221,693May 15 04:41 PM
PRSO - Peraso Inc - Stock Price Chart
TickerPRSO [NASD]
CompanyPeraso Inc
CountryUSA
IndustrySemiconductors
Market Cap6.23MEPS (ttm)-3.32
P/E-EPS this Y32.16%
Forward P/E-EPS next Y71.98%
PEG-EPS past 5Y40.44%
P/S0.40EPS next 5Y-
P/B1.67EPS Q/Q90.84%
Dividend-Sales Q/Q37.39%
Insider Own11.49%Inst Own6.36%
Insider Trans0.00%Inst Trans11.50%
Short Float3.02%EarningsMay 12/a
Analyst Recom1.00Target Price2.88
Avg Volume206.27K52W Range0.52 - 2.34
Peraso, Inc. engages in the development and sale of semiconductor devices and modules based on its proprietary semiconductor devices and performance of non-recurring engineering, services and licensing of intellectual property. It operates through the following geographical segments: North America, Hong Kong, Taiwan, and Rest of World. The company was founded in 1991 and is headquartered in San Jose, CA.
TEN - Tsakos Energy Navigation Limited - Stock Price Chart
TickerTEN [NYSE]
CompanyTsakos Energy Navigation Limited
CountryGreece
IndustryOil & Gas Midstream
Market Cap618.82MEPS (ttm)4.49
P/E4.58EPS this Y2.64%
Forward P/E3.08EPS next Y91.93%
PEG0.14EPS past 5Y-
P/S0.77EPS next 5Y33.53%
P/B0.36EPS Q/Q-35.29%
Dividend5.84%Sales Q/Q-2.25%
Insider Own29.15%Inst Own19.49%
Insider Trans0.00%Inst Trans8.21%
Short Float3.12%EarningsJun 17/b
Analyst Recom1.67Target Price30.00
Avg Volume332.15K52W Range13.40 - 30.40
Tsakos Energy Navigation Ltd. engages in the provision of seaborne crude oil and petroleum product transportation services. Its activities include the operation of crude tankers, product tankers, and liquefied natural gas carriers. The company was founded by Nikolas P. Tsakos and Michael Gordon Jolliffe in July 1993 and is headquartered in Athens, Greece.
SPPL - Simpple Ltd - Stock Price Chart
TickerSPPL [NASD]
CompanySimpple Ltd
CountrySingapore
IndustrySpecialty Industrial Machinery
Market Cap10.02MEPS (ttm)-1.18
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-35.79%
P/S3.54EPS next 5Y-
P/B5.59EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own40.15%Inst Own0.35%
Insider Trans0.00%Inst Trans14.48%
Short Float0.68%Earnings-
Analyst Recom-Target Price-
Avg Volume21.04K52W Range2.02 - 16.80
Simpple Ltd. engages in the provision of property technology space. It operates through the following segments: Robots, Software Services Rendered, and Others. The Robots segment refers to the sale of autonomous robotic cleaning equipment. The Software Services Rendered segment involves in the sale of facilities management applications. The company was founded by Jie Xiang Chong and Kah Kit Pat on August 24, 2002 and is headquartered in Singapore.
CRWV - CoreWeave Inc - Stock Price Chart
TickerCRWV [NASD]
CompanyCoreWeave Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap82.52BEPS (ttm)-
P/E-EPS this Y-314.31%
Forward P/E-EPS next Y79.29%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B39.28EPS Q/Q-
Dividend0.01%Sales Q/Q-
Insider Own44.55%Inst Own39.05%
Insider Trans-1.74%Inst Trans211.63%
Short Float5.66%EarningsMay 14/a
Analyst Recom2.55Target Price84.22
Avg Volume22.18M52W Range33.51 - 166.63
CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WHITMAN MARGARET CDirectorJun 14 '25Option Exercise0.001,28001,280Jun 17 07:21 PM
Agrawal NitinChief Financial OfficerJun 11 '25Option Exercise0.00122,3200184,555Jun 13 06:27 PM
McBee BranninChief Development OfficerMay 31 '25Option Exercise0.00109,3600109,360Jun 03 06:00 PM
Venturo Brian MChief Strategy OfficerMay 31 '25Option Exercise0.00109,3600233,180Jun 03 05:59 PM
Intrator Michael NCEO and PresidentMay 31 '25Option Exercise0.00109,36007,181,620Jun 03 05:57 PM
1456789101112131418